Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine Yields

News   Apr 16, 2018 | Original story from Horizon

 
Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine Yields
 
 
 

RELATED ARTICLES

Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass Spec

News

Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.

READ MORE

Combining Different Malaria Vaccines Could Reduce Cases by 91%

News

Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.

READ MORE

Targeting Epigenetic Proteins to Prevent Breast Cancer

News

Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy